Robert Weigle serves as CEO of NOWDiagnostics since April 2023, and has held the CEO position at Prime Genomics since October 2020. Weigle is also a Board Member at Tenon Medical, Inc. and previously led AEENA DX as CEO until March 2023. In addition, Weigle served as an Entrepreneur in Residence at DigitalDx Ventures, which focuses on investing in early-stage digital health companies. Weigle's extensive experience includes a prior role as CEO of Benvenue Medical from May 2009 to August 2020 and membership on the Board of Zyga from December 2013 to September 2017. Prior roles include Vice President of Sales, Marketing, and Reimbursement at THEROX from 2001 to April 2009. Weigle graduated from the University of California, Berkeley, between 1979 and 1983.
Sign up to view 0 direct reports
Get started
This person is not in any teams